BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4384082)

  • 21. [Propericiazine in the control of anti-social behavior].
    Roy PB; Ferguson K; St Jean A; Lee H; Ban TA
    Union Med Can; 1966 Dec; 95(12):1441-2. PubMed ID: 4385262
    [No Abstract]   [Full Text] [Related]  

  • 22. Propericiazine in psychiatric emergencies. A controlled comparative study.
    Ananth JV; Salib M; Ban TA; Lehmann HE
    Can Psychiatr Assoc J; 1972 Apr; 17(2):143-5. PubMed ID: 4402542
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of oligophrenic children and adolescents with propericiazine].
    Dostál T
    Act Nerv Super (Praha); 1968 Oct; 10(3):319. PubMed ID: 4387432
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progress in therapy. A remedy for character disorders].
    Rass Int Clin Ter; 1966 Jun; 46(11):615. PubMed ID: 4383987
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical expressions of aggressive behavior and their treatment].
    Montanini R; Mastruzzo A; Giovannucci M
    G Psichiatr Neuropatol; 1968; 96(3):567-76. PubMed ID: 4389866
    [No Abstract]   [Full Text] [Related]  

  • 26. Pericyazine in clinical practice.
    Jenner FA
    Laval Med; 1970 Jun; 41(6):796-804. PubMed ID: 5509701
    [No Abstract]   [Full Text] [Related]  

  • 27. [Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients].
    Bertolotti P; Spaggiari G
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1243-58. PubMed ID: 4968439
    [No Abstract]   [Full Text] [Related]  

  • 28. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P; Anglade P; Simon JP
    Encephale; 1970; 59(3):278-88. PubMed ID: 5496123
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M; Ananth JV; Ban TA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical study of oxaflumazine; its place among the neuroleptics].
    Deniker P; Ginestet D; Peron-Magnan P; Colonna L; Loo H
    Therapie; 1971; 26(1):227-33. PubMed ID: 5554766
    [No Abstract]   [Full Text] [Related]  

  • 31. [Propericiazine and behavior disorders in neurological diseases in childhood and adolescence].
    Giménez Roldán S; Campos Castelló J
    Arch Neurobiol (Madr); 1969; 32(3):331-46. PubMed ID: 4392861
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experience with Aolept in child psychiatry in institutions].
    Jacobs R
    Hippokrates; 1966 Nov; 37(22):911-5. PubMed ID: 4382700
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of psychiatric inpatients with mesoridazine.
    Krout BM; Stone CB
    Psychosomatics; 1969; 10(4):244-8. PubMed ID: 5808616
    [No Abstract]   [Full Text] [Related]  

  • 34. [Contribution to the study of the effect of propericiazine on character and behavior disorders observed in children and adolescents].
    Duché DJ; Bourcier G
    Rev Neuropsychiatr Infant; 1969 Mar; 17(3):165-71. PubMed ID: 4389568
    [No Abstract]   [Full Text] [Related]  

  • 35. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
    Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electroencephalographic studies of a triflumethyl-phenothiazine derivative].
    Itil TM
    Arzneimittelforschung; 1965 Jul; 15(7):817-9. PubMed ID: 5898686
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neuleptil--a new neuroleptic drug. (Preliminary report)].
    Klosińska B; Soszyńska D; Wierzbicki T
    Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1163-6. PubMed ID: 4384652
    [No Abstract]   [Full Text] [Related]  

  • 38. [Geriatric experiences with Aolep].
    Jansen W
    Munch Med Wochenschr; 1966 Sep; 108(39):1926-8. PubMed ID: 6014871
    [No Abstract]   [Full Text] [Related]  

  • 39. factors influencing response to major tranquilizer medications.
    Kimbell I; Overall JE; Faibish GM; Pokorny AD
    Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contribution to the treatment of character and behavior disorders by propericiazine as compared with earlier treatments].
    Filipe-Lourenço A; Lécuyer R; Koupernik C
    Rev Neuropsychiatr Infant; 1966; 14(7):617-24. PubMed ID: 4382962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.